BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arriazu E, Ruiz de Galarreta M, Cubero FJ, Varela-Rey M, Pérez de Obanos MP, Leung TM, Lopategi A, Benedicto A, Abraham-Enachescu I, Nieto N. Extracellular matrix and liver disease. Antioxid Redox Signal 2014;21:1078-97. [PMID: 24219114 DOI: 10.1089/ars.2013.5697] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang X, Lee F, Teng Y, Lingam CB, Chen Z, Sun M, Song Z, Balachander GM, Leo HL, Guo Q, Shah I, Yu H. Sequential drug delivery for liver diseases. Adv Drug Deliv Rev 2019;149-150:72-84. [PMID: 31734169 DOI: 10.1016/j.addr.2019.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Hong F, Wan L, Liu J, Huang K, Xiao Z, Zhang Y, Shi C. Histone methylation regulates Hif-1 signaling cascade in activation of hepatic stellate cells. FEBS Open Bio 2018;8:406-15. [PMID: 29511617 DOI: 10.1002/2211-5463.12379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lachiondo-Ortega S, Mercado-Gómez M, Serrano-Maciá M, Lopitz-Otsoa F, Salas-Villalobos TB, Varela-Rey M, Delgado TC, Martínez-Chantar ML. Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis. Cells 2019;8:E1575. [PMID: 31817258 DOI: 10.3390/cells8121575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Rada M, Lazaris A, Kapelanski-Lamoureux A, Mayer TZ, Metrakos P. Tumor microenvironment conditions that favor vessel co-option in colorectal cancer liver metastases: A theoretical model. Semin Cancer Biol 2021;71:52-64. [PMID: 32920126 DOI: 10.1016/j.semcancer.2020.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Frtús A, Smolková B, Uzhytchak M, Lunova M, Jirsa M, Hof M, Jurkiewicz P, Lozinsky VI, Wolfová L, Petrenko Y, Kubinová Š, Dejneka A, Lunov O. Hepatic Tumor Cell Morphology Plasticity under Physical Constraints in 3D Cultures Driven by YAP-mTOR Axis. Pharmaceuticals (Basel) 2020;13:E430. [PMID: 33260691 DOI: 10.3390/ph13120430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tian X, Zhao C, Guo J, Xie S, Yin F, Huo X, Zhang X. Carvedilol Attenuates the Progression of Hepatic Fibrosis Induced by Bile Duct Ligation. Biomed Res Int 2017;2017:4612769. [PMID: 28396867 DOI: 10.1155/2017/4612769] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
7 Moon MY, Kim HJ, Kim MJ, Uhm S, Park JW, Suk KT, Park JB, Kim DJ, Kim SE. Rap1 regulates hepatic stellate cell migration through the modulation of RhoA activity in response to TGF‑β1. Int J Mol Med 2019;44:491-502. [PMID: 31173168 DOI: 10.3892/ijmm.2019.4215] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Eissa LA, Kenawy HI, El-Karef A, Elsherbiny NM, El-Mihi KA. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Chem Biol Interact. 2018;294:91-100. [PMID: 30138605 DOI: 10.1016/j.cbi.2018.08.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
9 Van Haele M, Snoeck J, Roskams T. Human Liver Regeneration: An Etiology Dependent Process. Int J Mol Sci 2019;20:E2332. [PMID: 31083462 DOI: 10.3390/ijms20092332] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
10 Li M, Jiang M, Meng J, Tao L. Exosomes: Carriers of Pro-Fibrotic Signals and Therapeutic Targets in Fibrosis. Curr Pharm Des 2019;25:4496-509. [PMID: 31814552 DOI: 10.2174/1381612825666191209161443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
11 Li GY, Wang YJ, Zhao TJ, Peng Y. Signaling pathways related to role of hepatic sinusoidal endothelial cells in liver fibrosis. Shijie Huaren Xiaohua Zazhi 2016; 24(28): 3933-3939 [DOI: 10.11569/wcjd.v24.i28.3933] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Fabris L, Cadamuro M, Cagnin S, Strazzabosco M, Gores GJ. Liver Matrix in Benign and Malignant Biliary Tract Disease. Semin Liver Dis 2020;40:282-97. [PMID: 32162285 DOI: 10.1055/s-0040-1705109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
13 Ünver Saraydin S, Saraydin D, Şahin İnan ZD. A digital image analysis study on the disintegration kinetics of reticular fibers in the ethylene glycol-induced rat liver tissue. Microsc Res Tech 2020;83:1585-93. [PMID: 33220018 DOI: 10.1002/jemt.23554] [Reference Citation Analysis]
14 Kabir F, Nahar K, Rahman MM, Mamun F, Lasker S, Khan F, Yasmin T, Akter KA, Subhan N, Alam MA. Etoricoxib treatment prevented body weight gain and ameliorated oxidative stress in the liver of high-fat diet-fed rats. Naunyn Schmiedebergs Arch Pharmacol 2021;394:33-47. [PMID: 32780227 DOI: 10.1007/s00210-020-01960-9] [Reference Citation Analysis]
15 Geervliet E, Bansal R. Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases. Cells. 2020;9. [PMID: 32414178 DOI: 10.3390/cells9051212] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
16 Lyons H, Vouyoukas E, Higgins M, Maciejko JJ. Clinical and Histologic Liver Improvement in Siblings With Lysosomal Acid Lipase Deficiency After Enzyme Replacement. J Pediatr Gastroenterol Nutr 2020;70:635-9. [PMID: 32097366 DOI: 10.1097/MPG.0000000000002671] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Yoon YC, Fang Z, Lee JE, Park JH, Ryu JK, Jung KH, Hong SS. Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/ MAPK Pathway of Hepatic Stellate Cells. Biomol Ther (Seoul) 2020;28:527-36. [PMID: 32451370 DOI: 10.4062/biomolther.2020.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Willemse J, Verstegen MMA, Vermeulen A, Schurink IJ, Roest HP, van der Laan LJW, de Jonge J. Fast, robust and effective decellularization of whole human livers using mild detergents and pressure controlled perfusion. Mater Sci Eng C Mater Biol Appl 2020;108:110200. [PMID: 31923991 DOI: 10.1016/j.msec.2019.110200] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
19 Nimbalkar V, Vyawahare N. L-carnitine ameliorates bile duct ligation induced liver fibrosis via reducing the nitrosative stress in experimental animals: preclinical evidences. Heliyon 2021;7:e08488. [PMID: 34901512 DOI: 10.1016/j.heliyon.2021.e08488] [Reference Citation Analysis]
20 Wu SM, Li TH, Yun H, Ai HW, Zhang KH. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling. Yonsei Med J. 2019;60:561-569. [PMID: 31124340 DOI: 10.3349/ymj.2019.60.6.561] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
21 Özkan A, Stolley D, Cressman ENK, McMillin M, DeMorrow S, Yankeelov TE, Rylander MN. The Influence of Chronic Liver Diseases on Hepatic Vasculature: A Liver-on-a-chip Review. Micromachines (Basel) 2020;11:E487. [PMID: 32397454 DOI: 10.3390/mi11050487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
22 Weng X, Lin, Huang JTJ, Stimson RH, Wasserman DH, Kang L. Collagen 24 α1 Is Increased in Insulin-Resistant Skeletal Muscle and Adipose Tissue. Int J Mol Sci 2020;21:E5738. [PMID: 32785142 DOI: 10.3390/ijms21165738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Saydmohammed M, Jha A, Mahajan V, Gavlock D, Shun TY, DeBiasio R, Lefever D, Li X, Reese C, Kershaw EE, Yechoor V, Behari J, Soto-Gutierrez A, Vernetti L, Stern A, Gough A, Miedel MT, Lansing Taylor D. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. Exp Biol Med (Maywood) 2021;:15353702211009228. [PMID: 33957803 DOI: 10.1177/15353702211009228] [Reference Citation Analysis]
24 Chen G, Wang R, Chen H, Wu L, Ge RS, Wang Y. Gossypol ameliorates liver fibrosis in diabetic rats induced by high-fat diet and streptozocin. Life Sci 2016;149:58-64. [PMID: 26883980 DOI: 10.1016/j.lfs.2016.02.044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
25 Khanam A, Saleeb PG, Kottilil S. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 2021;10:1097. [PMID: 34064375 DOI: 10.3390/cells10051097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Vettori E, Costantinides F, Nicolin V, Rizzo R, Perinetti G, Maglione M, Di Lenarda R. Factors Influencing the Onset of Intra- and Post- Operative Complications Following Tooth Exodontia: Retrospective Survey on 1701 Patients. Antibiotics (Basel) 2019;8:E264. [PMID: 31847095 DOI: 10.3390/antibiotics8040264] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Khurana A, Sayed N, Allawadhi P, Weiskirchen R. It's all about the spaces between cells: role of extracellular matrix in liver fibrosis. Ann Transl Med 2021;9:728. [PMID: 33987426 DOI: 10.21037/atm-20-2948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
28 Abdelhamid AM, Youssef ME, Abd El-Fattah EE, Gobba NA, Gaafar AGA, Girgis S, Shata A, Hafez AM, El-Ahwany E, Amin NA, Shahien MA, Abd-Eldayem MA, Abou-Elrous M, Saber S. Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride. Life Sci 2021;286:120070. [PMID: 34688695 DOI: 10.1016/j.lfs.2021.120070] [Reference Citation Analysis]
29 Zhang Y, Li R, Rong W, Han M, Cui C, Feng Z, Sun X, Jin S. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis.Cell Death Dis. 2018;9:1186. [PMID: 30538216 DOI: 10.1038/s41419-018-1239-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
30 Sorrentino G, Rezakhani S, Yildiz E, Nuciforo S, Heim MH, Lutolf MP, Schoonjans K. Mechano-modulatory synthetic niches for liver organoid derivation. Nat Commun 2020;11:3416. [PMID: 32651372 DOI: 10.1038/s41467-020-17161-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
31 Williamson T, Sultanpuram N, Sendi H. The role of liver microenvironment in hepatic metastasis. Clin Transl Med 2019;8:21. [PMID: 31263976 DOI: 10.1186/s40169-019-0237-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
32 Ramot Y, Deshpande A, Morello V, Michieli P, Shlomov T, Nyska A. Microscope-Based Automated Quantification of Liver Fibrosis in Mice Using a Deep Learning Algorithm. Toxicol Pathol 2021;49:1126-33. [PMID: 33769147 DOI: 10.1177/01926233211003866] [Reference Citation Analysis]
33 Lefebvre P, Lalloyer F, Baugé E, Pawlak M, Gheeraert C, Dehondt H, Vanhoutte J, Woitrain E, Hennuyer N, Mazuy C, Bobowski-Gérard M, Zummo FP, Derudas B, Driessen A, Hubens G, Vonghia L, Kwanten WJ, Michielsen P, Vanwolleghem T, Eeckhoute J, Verrijken A, Van Gaal L, Francque S, Staels B. Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin. JCI Insight 2017;2:92264. [PMID: 28679947 DOI: 10.1172/jci.insight.92264] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 9.8] [Reference Citation Analysis]
34 Chen L, Brenner DA, Kisseleva T. Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis. Hepatol Commun. 2018;3:180-192. [PMID: 30766956 DOI: 10.1002/hep4.1290] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
35 Arafah A, Rehman MU, Mir TM, Wali AF, Ali R, Qamar W, Khan R, Ahmad A, Aga SS, Alqahtani S, Almatroudi NM. Multi-Therapeutic Potential of Naringenin (4',5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms. Plants (Basel) 2020;9:E1784. [PMID: 33339267 DOI: 10.3390/plants9121784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
36 Smith-Cortinez N, Fagundes RR, Gomez V, Kong D, de Waart DR, Heegsma J, Sydor S, Olinga P, de Meijer VE, Taylor CT, Bank R, Paulusma CC, Faber KN. Collagen release by human hepatic stellate cells requires vitamin C and is efficiently blocked by hydroxylase inhibition. FASEB J 2021;35:e21219. [PMID: 33236467 DOI: 10.1096/fj.202001564RR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Zhang G, Liu Y, Liu P. Active Components from Sea Buckthorn ( Hippophae rhamnoides L.) Regulate Hepatic Stellate Cell Activation and Liver Fibrogenesis. J Agric Food Chem 2018;66:12257-64. [PMID: 30398061 DOI: 10.1021/acs.jafc.8b05306] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
38 Reszegi A, Horváth Z, Karászi K, Regős E, Postniková V, Tátrai P, Kiss A, Schaff Z, Kovalszky I, Baghy K. The Protective Role of Decorin in Hepatic Metastasis of Colorectal Carcinoma. Biomolecules 2020;10:E1199. [PMID: 32824864 DOI: 10.3390/biom10081199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Brovold M, Keller D, Devarasetty M, Dominijanni A, Shirwaiker R, Soker S. Biofabricated 3D in vitro model of fibrosis-induced abnormal hepatoblast/biliary progenitors' expansion of the developing liver. Bioeng Transl Med 2021;6:e10207. [PMID: 34589593 DOI: 10.1002/btm2.10207] [Reference Citation Analysis]
40 Naim A, Baig MS. Matrix metalloproteinase-8 (MMP-8) regulates the activation of hepatic stellate cells (HSCs) through the ERK-mediated pathway. Mol Cell Biochem 2020;467:107-16. [PMID: 32108279 DOI: 10.1007/s11010-020-03705-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Hu XX, Wang Y, Wang JXY. Handan Ganle inhibits PI3K/Akt signaling pathway in liver fibrosis in rats. Shijie Huaren Xiaohua Zazhi 2014; 22(14): 1915-1920 [DOI: 10.11569/wcjd.v22.i14.1915] [Reference Citation Analysis]
42 Rastogi A, Patil N, Maiwall R, Bihari C, Soshee A, Sarin SK. Second-harmonic generation (SHG) microscopy and hepatic venous pressure gradient-based validation of a novel histological staging system for alcoholic hepatitis. Virchows Arch 2021. [PMID: 33797570 DOI: 10.1007/s00428-021-03089-3] [Reference Citation Analysis]
43 Sun J, Wang J, Zhang N, Yang R, Chen K, Kong D. Identification of global mRNA expression profiles and comprehensive bioinformatic analyses of abnormally expressed genes in cholestatic liver disease. Gene 2019;707:9-21. [PMID: 31048068 DOI: 10.1016/j.gene.2019.04.078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
44 Liu H, Zhang S, Xu S, Koroleva M, Small EM, Jin ZG. Myofibroblast-specific YY1 promotes liver fibrosis. Biochem Biophys Res Commun 2019;514:913-8. [PMID: 31084931 DOI: 10.1016/j.bbrc.2019.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
45 Ye X, He L, Ma J, Li Y, Zhang M, Yang J, Zhang J, Xiao F, Wei H. Downregulation of Glt25d1 aggravates carbon tetrachloride‑induced acute hepatic injury through activation of the TGF‑β1/Smad2 signaling pathway. Mol Med Rep 2018;18:3611-8. [PMID: 30132521 DOI: 10.3892/mmr.2018.9392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Karmacharya MB, Sultan LR, Kirkham BM, Brice AK, Wood AKW, Sehgal CM. Photoacoustic Imaging for Assessing Tissue Oxygenation Changes in Rat Hepatic Fibrosis. Diagnostics (Basel) 2020;10:E705. [PMID: 32957666 DOI: 10.3390/diagnostics10090705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Park YJ, Kim DM, Jeong MH, Yu JS, So HM, Bang IJ, Kim HR, Kwon SH, Kim KH, Chung KH. (-)-Catechin-7-O-β-d-Apiofuranoside Inhibits Hepatic Stellate Cell Activation by Suppressing the STAT3 Signaling Pathway. Cells 2019;9:E30. [PMID: 31861943 DOI: 10.3390/cells9010030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
48 Wang Q, Liu H, Zhu Z, Sheng Y, Du Y, Li Y, Liu J, Zhang J, Xing W. Feasibility of T1 mapping with histogram analysis for the diagnosis and staging of liver fibrosis: Preclinical results. Magn Reson Imaging 2021;76:79-86. [PMID: 33242591 DOI: 10.1016/j.mri.2020.11.006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Acun A, Oganesyan R, Uygun K, Yeh H, Yarmush ML, Uygun BE. Liver donor age affects hepatocyte function through age-dependent changes in decellularized liver matrix. Biomaterials 2021;270:120689. [PMID: 33524812 DOI: 10.1016/j.biomaterials.2021.120689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Hatipoglu OF, Uctepe E, Opoku G, Wake H, Ikemura K, Ohtsuki T, Inagaki J, Gunduz M, Gunduz E, Watanabe S, Nishinaka T, Takahashi H, Hirohata S. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition. Biomed Pharmacother 2021;139:111633. [PMID: 34243624 DOI: 10.1016/j.biopha.2021.111633] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Katsarou A, Moustakas II, Pyrina I, Lembessis P, Koutsilieris M, Chatzigeorgiou A. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(17): 1993-2011 [PMID: 32536770 DOI: 10.3748/wjg.v26.i17.1993] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
52 Yao X, Wang J, Zhu J, Rong X. The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis. Stem Cell Res Ther 2020;11:379. [PMID: 32883340 DOI: 10.1186/s13287-020-01891-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Verstegen MMA, Spee B, van der Laan LJW. Bioengineering Liver Transplantation. Bioengineering (Basel) 2019;6:E96. [PMID: 31623066 DOI: 10.3390/bioengineering6040096] [Reference Citation Analysis]
54 Eom JA, Kwon GH, Kim NY, Park EJ, Won SM, Jeong JJ, Raja G, Gupta H, Asmelash Gebru Y, Sharma S, Choi YR, Kim HS, Yoon SJ, Hyun JY, Jeong MK, Park HJ, Min BH, Choi MR, Kim DJ, Suk KT. Diet-Regulating Microbiota and Host Immune System in Liver Disease. Int J Mol Sci 2021;22:6326. [PMID: 34199182 DOI: 10.3390/ijms22126326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Zadorozhna M, Di Gioia S, Conese M, Mangieri D. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment. Mol Biol Rep 2020;47:2279-88. [PMID: 32040707 DOI: 10.1007/s11033-020-05290-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
56 Randles MJ, Woolf AS, Huang JL, Byron A, Humphries JD, Price KL, Kolatsi-Joannou M, Collinson S, Denny T, Knight D, Mironov A, Starborg T, Korstanje R, Humphries MJ, Long DA, Lennon R. Genetic Background is a Key Determinant of Glomerular Extracellular Matrix Composition and Organization. J Am Soc Nephrol 2015;26:3021-34. [PMID: 25896609 DOI: 10.1681/ASN.2014040419] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.9] [Reference Citation Analysis]
57 Fan W, Liu T, Chen W, Hammad S, Longerich T, Hausser I, Fu Y, Li N, He Y, Liu C, Zhang Y, Lian Q, Zhao X, Yan C, Li L, Yi C, Ling Z, Ma L, Zhao X, Xu H, Wang P, Cong M, You H, Liu Z, Wang Y, Chen J, Li D, Hui L, Dooley S, Hou J, Jia J, Sun B. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice. Gastroenterology 2019;157:1352-1367.e13. [PMID: 31362006 DOI: 10.1053/j.gastro.2019.07.036] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
58 Kim SJ, Kim KM, Yang JH, Cho SS, Jeong EH, Kim JH, Lee JH, Seo KH, Park EY, Ki SH. Transforming Growth Factor Beta-Induced Foxo3a Acts as a Profibrotic Mediator in Hepatic Stellate Cells. Toxicol Sci 2021;179:241-50. [PMID: 33372984 DOI: 10.1093/toxsci/kfaa185] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Lee HS, Choi J, Son T, Lee EJ, Kim JG, Ryu SH, Lee D, Jang MK, Yu E, Chung YH, Gelman IH, Kim KW. A-kinase anchoring protein 12 is downregulated in human hepatocellular carcinoma and its deficiency in mice aggravates thioacetamide-induced liver injury. Oncol Lett 2018;16:5907-15. [PMID: 30344741 DOI: 10.3892/ol.2018.9396] [Reference Citation Analysis]
60 Wang HH, Huang JH, Sue MH, Ho WC, Hsu YH, Chang KC, Chang MS. Interleukin-24 protects against liver injury in mouse models. EBioMedicine 2021;64:103213. [PMID: 33508745 DOI: 10.1016/j.ebiom.2021.103213] [Reference Citation Analysis]
61 Ying L, Yan F, Zhao Y, Gao H, Williams BR, Hu Y, Li X, Tian R, Xu P, Wang Y. (-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis-related genes in non-alcoholic fatty liver disease. Clin Exp Pharmacol Physiol 2017;44:1180-91. [PMID: 28815679 DOI: 10.1111/1440-1681.12844] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]